Evidence map›Paper›PMID 34253906›Full record

ArticleNature metabolism2021

Cell competition acts as a purifying selection to eliminate cells with mitochondrial defects during early mouse development.

Ana Lima, Gabriele Lubatti, Jörg Burgstaller, Di Hu, Alistair P Green, Aida Di Gregorio, Tamzin Zawadzki, Barbara Pernaute, Elmir Mahammadov, Salvador Perez-Montero and 11 more

Open access · greenAbstract read
In one paragraph

Article in Nature metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Mitochondrial curation for the next generation.Current opinion in genetics & development · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 5 countries.

Ana Lima *National Heart and Lung Institute, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-2821-7178
Gabriele Lubatti *Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, Munich, Germany.
Jörg BurgstallerInstitute of Animal Breeding and Genetics, University of Veterinary Medicine, Vienna, Austria.
Di HuDepartment of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.
Alistair P GreenEPSRC Centre for the Mathematics of Precision Healthcare, Department of Mathematics, Imperial College London, London, UK.
Aida Di GregorioNational Heart and Lung Institute, Imperial College London, London, UK.
Tamzin ZawadzkiNational Heart and Lung Institute, Imperial College London, London, UK.
Barbara PernauteNational Heart and Lung Institute, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-8706-1126
Elmir MahammadovInstitute of Epigenetics and Stem Cells, Helmholtz Zentrum München, Munich, Germany.ORCID http://orcid.org/0000-0003-0008-1413
Salvador Perez-MonteroNational Heart and Lung Institute, Imperial College London, London, UK.
Marian DoreMRC London Institute of Medical Sciences (LMS), Institute of Clinical Sciences, Imperial College London, London, UK.
Juan Miguel SanchezNational Heart and Lung Institute, Imperial College London, London, UK.
Sarah BowlingNational Heart and Lung Institute, Imperial College London, London, UK.
Margarida SanchoNational Heart and Lung Institute, Imperial College London, London, UK.
Thomas KolbeBiomodels Austria (Biat), University of Veterinary Medicine Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0003-2974-8066
Mohammad M KarimiMRC London Institute of Medical Sciences (LMS), Institute of Clinical Sciences, Imperial College London, London, UK.ORCID http://orcid.org/0000-0001-5017-1252
David CarlingMRC London Institute of Medical Sciences (LMS), Institute of Clinical Sciences, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-2316-1830
Nick JonesEPSRC Centre for the Mathematics of Precision Healthcare, Department of Mathematics, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-4083-972X
Shankar SrinivasDepartment of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-5726-7791
Antonio ScialdoneInstitute of Epigenetics and Stem Cells, Helmholtz Zentrum München, Munich, Germany. antonio.scialdone@helmholtz-muenchen.de.ORCID http://orcid.org/0000-0002-4956-2843
Tristan A RodriguezNational Heart and Lung Institute, Imperial College London, London, UK. tristan.rodriguez@imperial.ac.uk.ORCID http://orcid.org/0000-0002-3415-8493
Imperial College London · GBHelmholtz Zentrum München · DEMRC London Institute of Medical Sciences · GBEngineering and Physical Sciences Research Council · GBUniversity of Oxford · GBUniversity of Veterinary Medicine Vienna · ATCentre for Genomic Regulation · ESKing's College London · GBLung Institute · US

Funding

Biotechnology and Biological Sciences Research Council BB/L015129/1Biotechnology and Biological Sciences Research Council BB/S008284/1British Heart Foundation FS/14/62/31288British Heart Foundation FS/17/64/33476Medical Research Council MC_U120027537Medical Research Council MR/P018467/1Medical Research Council MR/T028637/1Wellcome Trust 103788Wellcome Trust 104931Wellcome Trust 104931/Z/14/ZWellcome Trust 108438Wellcome Trust 108438/Z/15/Z
6 · The paper itself

Abstract

Cell competition is emerging as a quality-control mechanism that eliminates unfit cells in a wide range of settings from development to the adult. However, the nature of the cells normally eliminated by cell competition and what triggers their elimination remains poorly understood. In mice, 35% of epiblast cells are eliminated before gastrulation. Here we show that cells with mitochondrial defects are eliminated by cell competition during early mouse development. Using single-cell transcriptional profiling of eliminated mouse epiblast cells, we identify hallmarks of cell competition and mitochondrial defects. We demonstrate that mitochondrial defects are common to a range of different loser cell types and that manipulating mitochondrial function triggers cell competition. Moreover, we show that in the mouse embryo, cell competition eliminates cells with sequence changes in mt-Rnr1 and mt-Rnr2, and that even non-pathological changes in mitochondrial DNA sequences can induce cell competition. Our results suggest that cell competition is a purifying selection that optimizes mitochondrial performance before gastrulation.

Indexed as

Cell CompetitionEmbryo, MammalianEmbryonic DevelopmentAnimalsBiomarkersGene Expression ProfilingGene Expression Regulation, DevelopmentalMiceMitochondriaSingle-Cell AnalysisBiomarkers

Identifiers

PMID34253906
PMCPMC7611553
OpenAlexW3181504157

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.